Jul 2 |
Equillium to Participate in Upcoming Investor Conferences
|
Jun 12 |
Equillium to join Russell Microcap Index
|
Jun 12 |
Equillium to be included in the Russell Microcap® Index
|
Jun 4 |
Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings
|
Jun 4 |
Equillium posts early mid-stage data for hair loss therapy
|
Jun 4 |
Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata
|
May 29 |
Equillium to Present at the Jefferies Global Healthcare Conference
|
May 14 |
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
|
May 9 |
Equillium GAAP EPS of -$0.08, revenue of $10.7M
|
May 9 |
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
|